Arbutus Biopharma Corp

Ownership Transactions Reported by 23 Insiders

Symbol
ABUS on Nasdaq
Industry
Pharmaceutical Preparations
Location
701 Veterans Circle, Warminster, PA

Insiders trading volume in the past year

Arbutus Biopharma Corp executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Matthew Gline Director, 10%+ Owner $128M Feb 24, 2025
Michael J. McElhaugh Interim President & CEO, Director $6.83M -$78.1K -1.13% Feb 14, 2025
Michael J. Sofia Chief Scientific Officer $5.05M Feb 1, 2024
William H. Collier President and CEO, Director $3.54M Feb 1, 2023
David C. Hastings Chief Financial Officer $2.08M -$72.8K -3.38% Feb 14, 2025
Karen Sims Chief Medical Officer $1.65M -$63.5K -3.72% Feb 14, 2025
J. Christopher Naftzger General Counsel and CCO $1.53M -$37.2K -2.37% Feb 14, 2025
Elizabeth Howard EVP, GC, Compliance $1.22M Feb 1, 2023
Gaston Picchio Chief Development Officer $721K Jan 20, 2022
Keith Manchester Director $358K -$32.6K -8.35% Aug 14, 2024
Richard C. Henriques Jr Director $188K May 23, 2024
James R. Meyers Director $188K May 23, 2024
Daniel D. Burgess Director $188K May 23, 2024
Frank Torti Director $188K May 23, 2024
Melissa Rewolinski Director $188K May 23, 2024
Tram Tran Director $115K May 25, 2022
Andrew Cheng Director $61.8K Jun 3, 2021
Lindsay Androski President and CEO, Director Mar 18, 2025
Tuan Nguyen Chief Financial Officer Mar 31, 2025
Joseph Bishop Director Feb 24, 2025
Anuj Hasija Director Mar 18, 2025
Roivant Sciences Ltd. 10%+ Owner Oct 18, 2021
Robert A. Beardsley Director Mar 18, 2025

Recent Insider Transactions by Companies or Individuals for Arbutus Biopharma Corp

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.